High expression levels of trigger receptor expressed on myeloid cells-1 on neutrophils associated with increased severity of acute pancreatitis in mice

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 10, 2015, Pages 1450-1457

  Liu, Mulin ^a   Wu, Wei ^a   Zhao, Qun ^a   Feng, Qiupeng ^a   Wang, Wenbin ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Acute pancreatitis; Cytokine; Inflammatory; Triggering receptor expressed on myeloid cell (TREM) 1

Indexed keywords

AMYLASE; ARGININE; BIOLOGICAL MARKER; CD14 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, MOUSE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; MOUSE; MOUSE MODEL; NEUTROPHIL; NONHUMAN; PANCREAS INJURY; PATHOGENESIS; PERITONEAL FLUID LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE; ANIMAL; ASCITES FLUID; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; METABOLISM; PANCREAS; PANCREATITIS; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

AMYLASES; ANIMALS; ARGININE; ASCITIC FLUID; BIOMARKERS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; MICE, INBRED BALB C; NEUTROPHILS; PANCREAS; PANCREATITIS; RECEPTORS, IMMUNOLOGIC; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84946914833     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00057     Document Type: Article

References (40)

1. Kylänpää L, Rakonczay Z Jr, O'Reilly DA. The clinical course of acute pancreatitis and the inflammatory mediators that drive it. Int. J. Inflam., 2012, 360685 (2012).
2. Garip G, Sarandol E, Kaya E. Effects of disease severity and necrosis on pancreatic dysfunction after acute pancreatitis. World J. Gastroenterol., 19, 8065-8070 (2013).
3. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA, 291, 2865-2868 (2004).
4. Petejova N, Martinek A. Acute kidney injury following acute pancreatitis: A review. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 157, 105-113 (2013).
5. Shrivastava P, Bhatia M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J. Gastroenterol., 16, 3995-4002 (2010).
6. Halonen KI, Pettilä V, Leppäniemi AK, Kemppainen EA, Puolakkainen PA, Haapiainen RK. Multiple organ dysfunction associated with severe acute pancreatitis. Crit. Care Med., 30, 1274-1279 (2002).
7. Juneja D, Gopal PB, Ravula M. Scoring systems in acute pancreatitis: which one to use in intensive care units? J. Crit. Care, 25, 358. e9-358.e15 (2010).
8. Williams M, Simms HH. Prognostic usefulness of scoring systems in critically ill patients with severe acute pancreatitis. Crit. Care Med., 27, 901-907 (1999).
9. Otsuki M, Takeda K, Matsuno S, Kihara Y, Koizumi M, Hirota M, Ito T, Kataoka K, Kitagawa M, Inui K, Takeyama Y. Criteria for the diagnosis and severity stratification of acute pancreatitis. World J. Gastroenterol., 19, 5798-5805 (2013).
10. Adamson WT, Hebra A, Thomas PB, Wagstaff P, Tagge EP, Othersen HB. Serum amylase and lipase alone are not cost-effective screening methods for pediatric pancreatic trauma. J. Pediatr. Surg., 38, 354-357, discussion, 354-357 (2003).
11. Herman R, Guire KE, Burd RS, Mooney DP, Ehlrich PF. Utility of amylase and lipase as predictors of grade of injury or outcomes in pediatric patients with pancreatic trauma. J. Pediatr. Surg., 46, 923-926 (2011).
12. Kumar S, Sagar S, Subramanian A, Albert V, Pandey RM, Kapoor N. Evaluation of amylase and lipase levels in blunt trauma abdomen patients. J. Emerg. Trauma Shock, 5, 135-142 (2012).
13. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol., 164, 4991-4995 (2000).
14. Nathan C, Ding A. TREM-1: a new regulator of innate immunity in sepsis syndrome. Nat. Med., 7, 530-532 (2001).
15. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature, 410, 1103-1107 (2001).
16. Su L, Liu C, Li C, Jiang Z, Xiao K, Zhang X, Li M, Yan P, Feng D, Xie L. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Inflammation, 35, 1833-1843 (2012).
17. Oku R, Oda S, Nakada TA, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Ito M, Iseki T, Hirasawa H. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine, 61, 112-117 (2013).
18. Latour-Pérez J, Alcalá-López A, García-García MA, Sánchez-Hernández JF, Abad-Terrado C, Viedma-Contreras JA, Masiá M, González-Tejera M, Arizo-León D, Porcar MJ, Bonilla-Rovira F, Gutiérrez F. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clin. Biochem., 43, 720-724 (2010).
19. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J. Immunol., 170, 3812-3818 (2003).
20. Keceli M, Kucuk C, Sozuer E, Kerek M, Ince O, Arar M. The effect of interleukin-10 on acute pancreatitis induced by cerulein in a rat experimental model. J. Invest. Surg., 18, 7-12 (2005).
21. Mizunuma T, Kawamura S, Kishino Y. Effects of injecting excess arginine on rat pancreas. J. Nutr., 114, 467-471 (1984).
22. Delaney CP, McGeeney KF, Dervan P, Fitzpatrick JM. Pancreatic atrophy: a new model using serial intra-peritoneal injections of L-arginine. Scand. J. Gastroenterol., 28, 1086-1090 (1993).
23. Su KH, Cuthbertson C, Christophi C. Review of experimental animal models of acute pancreatitis. HPB (Oxford), 8, 264-286 (2006).
24. Weaver C, Bishop AE, Polak JM. Pancreatic changes elicited by chronic administration of excess L-arginine. Exp. Mol. Pathol., 60, 71-87 (1994).
25. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol., 29, 71-109 (2011).
26. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology, 112, 960-967 (1997).
27. Adly AA, Ismail EA, Andrawes NG, El-Saadany MA. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Cytokine, 65, 184-191 (2014).
28. Palmiere C, Bardy D, Mangin P, Augsburger M. Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis. J. Infect., 67, 545-555 (2013).
29. Zhang J, She D, Feng D, Jia Y, Xie L. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infect. Dis., 11, 53 (2011).
30. Wang F, Liu S, Wu S, Zhu Q, Ou G, Liu C, Wang Y, Liao Y, Sun Z. Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis. Cell. Immunol., 272, 251-258 (2012).
31. Weber B, Schuster S, Zysset D, Rihs S, Dickgreber N, Schurch C, Riether C, Siegrist M, Schneider C, Pawelski H, Gurzeler U, Ziltener P, Genitsch V, Tacchini-Cottier F, Ochsenbein A, Hofstetter W, Kopf M, Kaufmann T, Oxenius A, Reith W, Saurer L, Mueller C. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog., 10, e1003900 (2014).
32. Ubagai T, Nakano R, Kikuchi H, Ono Y. Gene expression analysis of TREM1 and GRK2 in polymorphonuclear leukocytes as the sur rogate biomarkers of acute bacterial infections. Int. J. Med. Sci., 11, 215-221 (2014).
33. Wang DY, Qin RY, Liu ZR, Gupta MK, Chang Q. Expression of TREM-1 mRNA in acute pancreatitis. World J. Gastroenterol., 10, 2744-2746 (2004).
34. Kylänpää ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World J. Gastroenterol., 16, 2867-2872 (2010).
35. Chen X, Wu H, Huang X, Wu X. [The alteration of inflammatory cytokine during acute pancreatitis]. Hua Xi Yi Ke Da Xue Xue Bao, 33, 238-240, 243 (2002).
36. Demydov VM, Zaporozhchenko BS, Demidov SM. [Changes of cytokine levels in the serum in patients with acute pancreatitis as an early symptom for diagnosis]. Klin Khir, 2003, 29-32 (2003).
37. Warzecha Z, Dembinski A, Ceranowicz P, Konturek SJ, Tomaszewska R, Stachura J, Konturek PC. IGF-1 stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis. J. Physiol. Pharmacol., 54, 575-590 (2003).
38. Fisic E, Poropat G, Bilic-Zulle L, Licul V, Milic S, Stimac D. The role of IL-6, 8, and 10, sTNFr, CRP, and pancreatic elastase in the prediction of systemic complications in patients with acute pancreatitis. Gastroenterol. Res. Pract., 2013, 282645 (2013).
39. Derive M, Massin F, Gibot S. Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases. Self Nonself, 1, 225-230 (2010).
40. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N, Figueroa-Figueroa S, Duarte-Rojo A, Guzmán-Valdivia-Gómez G, Rodea-Rosas H, Torres-González R, Sánchez-Fernández P, Arriaga-Pizano L, López-Macías C, Robles-Díaz G, Isibasi A. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit. Care, 13, R69 (2009).